Emory University Blueprint Medicines Corp Put Options Transaction History
Emory University
- $145 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
321Shares Held
60.5MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$711 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$696 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$690 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$461 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$276 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.59B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...